Seeking Alpha

Arena Pharmaceuticals (ARNA +38%) resumes trading at $13.50 following the FDA's approval of its...

Arena Pharmaceuticals (ARNA +38%) resumes trading at $13.50 following the FDA's approval of its weight-loss drug Belviq - formerly known as lorcaserin.
Comments (9)
  • Congrats to Arena and all Investors !!!!
    27 Jun 2012, 01:59 PM Reply Like
  • thank you hard to really make a decision when 25% of the shares were people on the short side!!!
    27 Jun 2012, 02:09 PM Reply Like
  • I continued to go long on ARNA through yeaterday afternoon. Great to be on the right side for a change
    27 Jun 2012, 02:22 PM Reply Like
  • me too only 300 shares to play it safe and not lose big in case FDA got bipolar on us!!!
    27 Jun 2012, 02:25 PM Reply Like
  • only 300 for me also, but had bought and sold for a 64% gain before the announcement today.

     

    Solomon asked for one thing....WISDOM
    27 Jun 2012, 03:30 PM Reply Like
  • ret. broker.....followed this co. for 4 years......finally, a biotech winner!!!!!
    27 Jun 2012, 03:52 PM Reply Like
  • Yes I bought and sold a couple of times and did good!! Always small positons Patience is a tribute!!! sold my 300 today I will wait ntil the dust settles!!
    27 Jun 2012, 03:56 PM Reply Like
  • Maria, dust has settled i $9.90's. Time to buy back in under $10. Should see $13/shr again shortly. IMHO
    2 Jul 2012, 05:59 PM Reply Like
  • yes it has especially if VVUS gets the approval or not!!
    2 Jul 2012, 06:24 PM Reply Like
DJIA (DIA) S&P 500 (SPY)